On October 1, 2009, two weeks before it celebrated its one-year anniversary, PharmaLegacy was granted full accreditation from the Association for Assessment and Accreditation of Laboratory Animal Care (AAALAC) for its pre-clinical animal lab. Shanghai-based PharmaLegacy is a CRO dedicated to preclinical pharmacology, with special expertise in three major disease areas: bone/orthopedic research, inflammation/immune diseases, and oncology More details...